Dostinex (Cabergoline): Comprehensive Patient Guide
Basic Product Information
| International Nonproprietary Name (INN) | Cabergoline |
|---|---|
| Brand Name(s) in Australia | Dostinex®, Cabaser®, Generic Cabergoline |
| ATC Code | G02CB03 |
| Available Forms & Strengths | Tablets: 0.5 mg |
| Manufacturer(s) | Pfizer Australia, Generic manufacturers |
| Prescription Status | Prescription Only Medicine (Schedule 4, S4) |
Mechanism of Action
For Patients: Dostinex contains cabergoline, which lowers the amount of a natural hormone called prolactin in your body. High prolactin can cause unwanted symptoms, and Dostinex helps bring those levels back to normal.
For Specialists: Cabergoline is a potent, long-acting dopamine D2 receptor agonist. It works primarily by inhibiting prolactin secretion from the anterior pituitary lactotroph cells, thereby reducing serum prolactin concentrations. Secondary effects include modulation of hypothalamo-pituitary neuronal pathways.
Pharmacokinetics
- Absorption: After oral administration, cabergoline is rapidly absorbed (peak blood levels in 0.5–4 hours).
- Bioavailability: Not significantly affected by food.
- Metabolism: Extensively metabolised in the liver, mainly via hydrolysis to inactive metabolites.
- Elimination: Eliminated mainly via bile and faeces, with a small part by urine (<4%).
- Duration of Action: Long half-life (63–68 hours); effects last 1–2 weeks after a single dose.
Use in Everyday Life and Best Practices (Australia Context)
Dostinex is most commonly used to treat conditions associated with high prolactin levels (hyperprolactinaemia), such as:
- Prolactin-secreting pituitary tumours (prolactinomas)
- Menstrual problems (irregular or absent periods)
- Infertility due to excess prolactin
- Unintended breast milk production in women not breastfeeding (galactorrhoea)
- Pituitary disorders in both men and women
- Off-label: Symptom relief for Parkinson’s disease (usually higher doses as Cabaser®, under specialist care)
- Always take Dostinex exactly as your doctor prescribes.
- Tablets can be cut in half for accurate dosing.
- Avoid abruptly stopping this medicine; consult your doctor first.
- Regular blood tests to monitor prolactin and liver function are common practice in Australia.
Dosing: Morning vs Evening
- Morning dosing: May cause less disturbed sleep but can increase risk of nausea — consider after breakfast.
- Evening dosing: Convenient for many, but may cause sleep disturbances in sensitive individuals.
Tips for Regularity: - Take the tablet at the same time(s) each week.
- Use a calendar, pillbox, or set a phone reminder.
Taking with Food or on an Empty Stomach
- You can take Dostinex with or without food.
- Taking it with food can help reduce nausea or stomach discomfort (a common side effect).
- No specific dietary restrictions for the typical Australian diet.
- Alcohol should be limited or avoided; see interaction section below.
Interaction Warnings
| Substance/Group | Effect/Interaction | Recommended Action |
|---|---|---|
| Alcohol | May increase side effects like dizziness, fainting | Avoid or minimise alcohol intake while taking Dostinex |
| Antihypertensive drugs | Enhanced blood pressure lowering effect | Monitor BP; report dizziness or fainting |
| Other dopamine agonists (e.g., bromocriptine, levodopa) | Increased risk of excessive dopamine activity or side effects | Specialist guidance required |
| Antipsychotics (e.g., risperidone, chlorpromazine) | May reduce effectiveness of cabergoline | Discuss alternatives with your doctor |
| Macrolide antibiotics (e.g., erythromycin) | May increase cabergoline blood levels | Use with caution; doctor may adjust your dose |
| High protein foods | No significant effect | No dietary adjustment needed |
Indications
| Indication | Official/TGA registered? | Off-label in Australia? |
|---|---|---|
| Treatment of hyperprolactinaemia (prolactin excess) | Yes | No |
| Suppression of normal lactation (postpartum) | No (use discouraged unless medically necessary) | Rarely |
| Parkinson’s disease (as Cabaser) | Yes (specialist use) | No |
| Acromegaly, Cushing’s disease, other pituitary disorders | No | Yes (specialist off-label use) |
| Infertility related to high prolactin | Yes | No |
Dosing According to Clinical Indications
| Indication | Adult Dose | Child/Adolescent Dose | Elderly Dose / Comments |
|---|---|---|---|
| Hyperprolactinaemia | Start: 0.5 mg/week (in 1–2 divided doses); increase by 0.5 mg every 4 weeks (max 2 mg/week) | Not generally recommended; rare specialist use | Same as adults, but start lower and titrate slowly due to risk of low blood pressure |
| Parkinson’s disease | Initial: 0.5 mg daily, increased weekly to 2–3 mg/day (as Cabaser; strictly specialist use) | Not recommended | Careful titration; monitor for psychiatric side effects |
| Suppression of lactation (not routinely recommended) | 1 mg single dose | Not recommended | Use with caution; balance risks vs benefits |
Safety Profile and Side Effects
Most people tolerate Dostinex well. However, like all medicines, cabergoline can cause side effects:
| Frequency | Side Effects | Actions/Warnings |
|---|---|---|
| Common (≥1/100) |
| Take with food; stand up slowly; see pharmacist if persistent |
| Uncommon (≥1/1,000) |
| Monitor symptoms & discuss with your GP if ongoing |
| Rare (<1/1,000) |
| Report new chest pain, breathing problems, or severe mood changes immediately |
Guidelines for Proper Use
- Store Dostinex tablets at room temperature away from moisture and sunlight.
- Take missed doses as soon as you remember, but do not double up if it’s almost time for the next dose.
- Dispose of unused or expired medicine via your local pharmacy’s disposal service (in line with Australian environmental and safety guidelines).
- Ask your pharmacist about compliance aids (e.g., dosettes, pill-reminder apps).
- Notify your doctor before any planned surgery or new medicines—including over-the-counter and complementary products.
- Tell your healthcare provider if you experience chest pain, breathlessness, swelling, severe mood changes, or compulsive behaviour.
- Regular follow-up is standard practice in Australia: blood tests and, for long-term users, possible echocardiograms to screen for rare heart valve problems.
Alternative Treatment Options
- Bromocriptine (Parlodel): Less potent, shorter acting, more gastrointestinal side effects. Listed on the PBS (Pharmaceutical Benefits Scheme); generic available.
- Quinagolide (Norprolac): Once-daily dosing; not widely available in Australia but used overseas in similar settings.
- Transsphenoidal surgery: For large pituitary tumours unresponsive to medication (specialist-only).
- Radiotherapy: Reserved for resistant cases—rarely used nowadays.
Comparative overview: Cabergoline is superior for long-term management, fewer side effects, and once/twice per week dosing. Bromocriptine is more established but less convenient due to frequent dosing and higher stomach upset. Surgery and radiotherapy are last resort options in modern Australian practice.
Legal, Registration, and Reimbursement Status in Australia
- Registration: Dostinex (cabergoline) is registered with the TGA (Therapeutic Goods Administration).
- Legal Status: Prescription Only (Schedule 4/S4).
- Reimbursement: Listed on the PBS (Pharmaceutical Benefits Scheme) for approved indications (hyperprolactinaemia and Parkinson's disease, specialist authority required for some uses).
- Pharmacist or GP prescription required; ongoing supplies usually via community pharmacy.
- PBS listing means lower out-of-pocket costs for eligible patients (Medicare card holders).
Latest Research & Clinical Guidance (2022–2025)
- Endocrine Society Australia, 2023: Cabergoline remains first-line for hyperprolactinaemia; regular monitoring recommended for long-term users, including heart and lung checks for high cumulative doses.
- Royal Australian and New Zealand College of Psychiatrists (RANZCP) 2024: Specialist consultation advised for any psychiatric history; cabergoline can rarely cause or worsen mood/impulse disorders.
- {{Recent publication: Bowden et al, Medicine Today, 2024}}: “Cabergoline continues to outperform bromocriptine in patient adherence and symptom control; monitoring is essential in those requiring more than two years of therapy.”
- New research ongoing into use for resistant pituitary tumours and off-label conditions.
Availability and Delivery
| Pack Size | Quantity | Indicative Retail Price (AUD, 2024) |
|---|---|---|
| Small pack | 8 tablets (0.5 mg each) | $31–$45 |
| Large pack (PBS) | 30 tablets (0.5 mg each) | $120–$140 ($30–$40 with PBS subsidy) |
Australian pharmacy home delivery is widely available, including express and standard options. Indicative delivery times:
| City/Region | Standard Delivery | Express/Overnight Delivery |
|---|---|---|
| Sydney, Melbourne, Brisbane | 1–3 business days | Same or next business day |
| Perth, Adelaide, Hobart | 2–4 business days | 1–2 business days |
| Regional/rural | 3–7 business days | 2–3 business days |
Frequently Asked Questions (FAQ)
- How long does Dostinex take to work?
Many patients see prolactin levels fall within a few days, but symptom improvement may take several weeks. Blood tests usually confirm progress within 4–8 weeks. - Can Dostinex be used in pregnancy or while breastfeeding?
Dostinex is generally not used during pregnancy or breastfeeding, except under specialist advice. Always inform your doctor if you are planning a pregnancy or become pregnant. - What should I do if I miss a dose?
Take the missed dose as soon as possible, unless it’s almost time for your next scheduled dose. Do not double-dose. Inform your doctor if you forget two or more doses. - Is it safe to drive or use machinery on Dostinex?
Some people may feel dizzy or drowsy, especially at treatment start. Do not drive or operate machinery until you know how Dostinex affects you. - Can I drink alcohol while taking Dostinex?
It is safest to limit or avoid alcohol, as it may increase the risk of certain side effects such as dizziness.
For more support: Please speak to your pharmacist, GP, or specialist for advice tailored to your health needs in Australia, or consult official resources such as the Australian Medicines Handbook and PBS Medicine Finder.
